Cargando…

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)

PURPOSE: FOLFOXIRI plus bevacizumab is regarded as a first-line therapeutic option for selected patients with metastatic colorectal cancer (mCRC). Our aim was to assess the efficacy and safety of induction treatment with FOLFOXIRI plus bevacizumab in patients with untreated mCRC harboring UGT1A1 wil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinozaki, Katsunori, Yamada, Takeshi, Nasu, Junichiro, Matsumoto, Toshihiko, Yuasa, Yasuhiro, Shiraishi, Takeshi, Nagano, Hiroaki, Moriyama, Ichiro, Fujiwara, Toshiyoshi, Miguchi, Masashi, Yoshida, Ryosuke, Nozaka, Kimiyasu, Tanioka, Hiroaki, Nagasaka, Takeshi, Kurisu, Yasuro, Kobayashi, Michiya, Tsuchihashi, Kenji, Inukai, Michio, Kikuchi, Takashi, Nishina, Tomohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819906/ https://www.ncbi.nlm.nih.gov/pubmed/33097971 http://dx.doi.org/10.1007/s10147-020-01811-w

Ejemplares similares

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C(3)) study
por: Nagasaka, Takeshi, et al.
Publicado: (2016)

Betri Pintoreta : novela infantil ilustrada en español e inglés
por: López Ardilla, Walter Alonso

Transfusional practices: what have we learnt with Transfusion Requirements In Critical Care (TRICC)
por: Mendes, CL, et al.
Publicado: (2003)

Red cell transfusion triggers in critically ill patients: time for some new TRICCs?
por: Walsh, Timothy S
Publicado: (2010)

Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial
por: Hirst, Yasemin, et al.
Publicado: (2016)

Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial
por: Hirst, Yasemin, et al.
Publicado: (2017)

1414. #Vaccine Twitter Influencers: is it Just About Reach and Followers?
por: Poirrier, Jean-Etienne, et al.
Publicado: (2020)

Upregulation of microRNA-31 is associated with poor prognosis in patients with advanced colorectal cancer
por: Kubota, Nobuhito, et al.
Publicado: (2020)

Efficacy and Toxicity of Folfoxiri for Patients with Metastatic Colorectal Cancer
por: Huy, Trinh Le, et al.
Publicado: (2019)

Survey on the Treatment of Postherpetic Neuralgia in Korea; Multicenter Study of 1,414 Patients
por: Nahm, Francis Sahngun, et al.
Publicado: (2013)

1414. Inoculum Effect of Piperacillin/Tazobactam Concentration on Emergence of Resistance in Klebsiella aerogenes
por: Custodio, Marco, et al.
Publicado: (2018)

Correlation Analysis and Prediction Model of Thermal Protection Performance of Aramid 1414 Fabric
por: Zhang, Zhemin, et al.
Publicado: (2023)

FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells
por: Ramzy, George M., et al.
Publicado: (2022)

Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study
por: Kitagawa, Yusuke, et al.
Publicado: (2020)

Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study
por: Tsuruta, Atsushi, et al.
Publicado: (2016)

FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?
por: Lamarca, Angela, et al.
Publicado: (2020)

Effectiveness of distal tibial osteotomy with distraction arthroplasty in varus ankle osteoarthritis
por: Nozaka, Koji, et al.
Publicado: (2020)

CERN - Laboratory I - Call for tenders No. I-1414: Specification for Sections for a Linear Accelerator
Publicado: (1975)

The Evangelismos hospital central nervous system tumor registry: Analysis of 1414 cases (1998-2009)
por: Stranjalis, George, et al.
Publicado: (2013)

The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma
por: Leaker, Brian R, et al.
Publicado: (2014)

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer
por: Taniguchi, Fumitaka, et al.
Publicado: (2021)

Liver resection following FOLFOXIRI plus bevacizumab: a detailed pathological review
por: Walter, H, et al.
Publicado: (2013)

Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
por: Sunakawa, Yu, et al.
Publicado: (2018)

Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy
por: Tamura, Nobumasa, et al.
Publicado: (2020)

FOLFOXIRI in Pregnant Women with Colorectal Cancer: A Case Report and Review of the Literature
por: Kozai, Landon, et al.
Publicado: (2022)

Ilizarov external fixation for a periprosthetic tibial fracture in severe osteoporosis: a case report
por: Nozaka, Koji, et al.
Publicado: (2020)

Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases
por: Satake, Hironaga, et al.
Publicado: (2021)

Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
por: Matsumoto, Michinori, et al.
Publicado: (2021)

Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study
por: Yamaguchi, Yoshiyuki, et al.
Publicado: (2020)

Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study
por: Yamaguchi, Yoshiyuki, et al.
Publicado: (2022)

Identification of cooperative genes for E2A‐PBX1 to develop acute lymphoblastic leukemia
por: Sera, Yasuyuki, et al.
Publicado: (2016)

FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases
por: Antoniotti, Carlotta, et al.
Publicado: (2022)

Editorial Comment to Syndrome of inappropriate antidiuretic hormone secretion as a side effect of chemotherapy for testicular cancer: A case report
por: Yuasa, Takeshi
Publicado: (2019)

Editorial Comment to Possible abscopal effect in urothelial carcinoma of the upper urinary tract after treatment with immune checkpoint inhibitors
por: Yuasa, Takeshi
Publicado: (2019)

Editorial comment from Dr Yuasa to Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
por: Yuasa, Takeshi
Publicado: (2020)

Editorial Comment from Dr Yuasa to Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma
por: Yuasa, Takeshi
Publicado: (2020)

A novel classification for local recurrence after surgical removal of renal cell cancer
por: Yuasa, Takeshi
Publicado: (2020)

Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
por: Yuasa, Takeshi
Publicado: (2021)

Editorial Comment to Cystic partially differentiated nephroblastoma in a 74‐year‐old patient
por: Yuasa, Takeshi
Publicado: (2021)

Editorial Comment to A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy
por: Yuasa, Takeshi
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hk4cq952q3e9gunn6fpvs2dvcu